aTYR PHARMA INC Total Assets
aTYR PHARMA INC (ATYR) had Total Assets of $69.83 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Assets
us-gaap:Assets · last filed 2026-08-07
- 2026-06-30: Assets $69.83M.
- 2026-03-31: Assets $79.65M.
- 2025-12-31: Assets $93.00M.
- 2025-09-30: Assets $106.65M.
| Period end | Assets |
|---|---|
| 2026-06-30 | $69.83M 10-Q · filed 2026-08-07 |
| 2026-03-31 | $79.65M 10-Q · filed 2026-05-15 |
| 2025-12-31 | $93.00M 10-Q · filed 2026-08-07 |
| 2025-09-30 | $106.65M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $101.53M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $97.25M 10-Q · filed 2025-05-07 |
| 2024-12-31 | $96.83M 10-K · filed 2026-03-05 |
| 2024-09-30 | $91.62M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $105.94M 10-Q · filed 2024-08-13 |
| 2024-03-31 | $113.25M 10-Q · filed 2024-05-02 |
| 2023-12-31 | $120.65M 10-K · filed 2025-03-13 |
| 2023-09-30 | $125.07M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $132.75M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $136.84M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $95.79M 10-K · filed 2024-03-14 |
| 2022-09-30 | $96.06M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $96.02M 10-Q · filed 2022-08-15 |
| 2022-03-31 | $104.78M 10-Q · filed 2022-05-10 |
| 2021-12-31 | $115.54M 10-K · filed 2023-03-14 |
| 2021-09-30 | $123.92M 10-Q · filed 2021-11-12 |
| 2021-06-30 | $48.99M 10-Q · filed 2021-08-11 |
| 2021-03-31 | $55.13M 10-Q · filed 2021-05-14 |
| 2020-12-31 | $38.73M 10-K · filed 2022-03-15 |
| 2020-09-30 | $41.64M 10-Q · filed 2020-11-13 |
| 2020-06-30 | $47.56M 10-Q · filed 2020-08-13 |
| 2020-03-31 | $54.45M 10-Q · filed 2020-05-12 |
| 2019-12-31 | $36.19M 10-K · filed 2021-03-24 |
| 2019-09-30 | $43.74M 10-Q · filed 2019-11-14 |
| 2019-06-30 | $48.76M 10-Q · filed 2019-08-14 |
| 2019-03-31 | $49.91M 10-Q · filed 2019-05-14 |
| 2018-12-31 | $52.75M 10-K · filed 2020-03-26 |
| 2018-09-30 | $59.77M 10-Q · filed 2018-11-14 |
| 2018-06-30 | $68.31M 10-Q · filed 2018-08-14 |
| 2018-03-31 | $78.47M 10-Q · filed 2018-05-15 |
| 2017-12-31 | $89.36M 10-K · filed 2019-03-26 |
| 2017-09-30 | $94.49M 10-Q · filed 2017-11-14 |
| 2017-06-30 | $61.47M 10-Q · filed 2017-08-14 |
| 2017-03-31 | $65.73M 10-Q · filed 2017-05-11 |
| 2016-12-31 | $80.52M 10-K · filed 2018-03-20 |
| 2016-09-30 | $85.92M 10-Q · filed 2016-11-14 |
| 2016-06-30 | $100.49M 10-Q · filed 2016-08-10 |
| 2016-03-31 | $115.13M 10-Q · filed 2016-05-11 |
| 2015-12-31 | $129.68M 10-K · filed 2017-03-16 |
| 2015-09-30 | $141.37M 10-Q · filed 2015-11-10 |
| 2015-06-30 | $153.08M 10-Q · filed 2015-08-12 |
| 2015-03-31 | $59.91M 10-Q · filed 2015-06-18 |
| 2014-12-31 | $20.64M 10-K · filed 2016-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B |